Home   Categories   Grid

Subscribe Now

STORM Therapeutics partners with FutureNeuro to explore epilepsy treatments

STORM Therapeutics partners with FutureNeuro to explore epilepsy treatments

STORM Therapeutics partners with FutureNeuro to explore epilepsy treatments

25 September 2020

It will initially study treatments in temporal lobe epilepsy.


Steroid improves survival chances of sickest Covid-19 patients, study involving Cambridge University Hospitals finds

Steroid improves survival chances of sickest Covid-19 patients, study involving Cambridge University Hospitals finds

Steroid improves survival chances of sickest Covid-19 patients, study involving Cambridge University Hospitals finds

17 September 2020

Patients had up to a 93 per cent chance of a better outcome.


Abcam plots £500m revenues by 2023-24

Abcam plots £500m revenues by 2023-24

Abcam plots £500m revenues by 2023-24

17 September 2020

The Cambridge Biomedical Campus-based company has announced its annual results.


Lost connections in the brains of mice with Alzheimer’s restored by MRC LMB in Cambridge

Lost connections in the brains of mice with Alzheimer’s restored by MRC LMB in Cambridge

Lost connections in the brains of mice with Alzheimer’s restored by MRC LMB in Cambridge

11 September 2020

Its artificial molecule also improved the movement and co-ordination of mice with spinal cord injuries.


AstraZeneca, GSK and Pfizer CEOs among nine to sign Covid-19 vaccine pledge

AstraZeneca, GSK and Pfizer CEOs among nine to sign Covid-19 vaccine pledge

AstraZeneca, GSK and Pfizer CEOs among nine to sign Covid-19 vaccine pledge

08 September 2020

They pledge to put patient safety first after international concerns over speed that Russia approved a coronavirus vaccine.


Axol Bioscience appoints new CEO to drive growth

Axol Bioscience appoints new CEO to drive growth

Axol Bioscience appoints new CEO to drive growth

02 September 2020

The Chesterford Research Park-based company specialises in providing human cell products.


Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

Liverpool School of Tropical Medicine to validate Avacta’s saliva-based Covid-19 test

12 August 2020

The company has also announced BBI Group as manufacturer for the test it is creating with Cytiva.

1

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

Horizon Discovery reports six-month loss following Covid-19 impact, but aids researchers’ efforts to fight virus

06 August 2020

The Waterbeach-based gene editing company says it is encouraged by its prospects for the rest of 2020.


Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

Avacta extends partnership with Daewoong Pharmaceutical and AffyXell Therapeutics for Covid-19 stem cell treatments

05 August 2020

They will also prepare for future pandemics.


NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

NASDAQ listing expected as F-star Therapeutics announces merger with Spring Bank Pharmaceuticals

03 August 2020

The combined company will be headquartered at Babraham Research Campus and in Cambridge, Massachusetts.


AstraZeneca’s new medicines power its growth in first half of year

AstraZeneca’s new medicines power its growth in first half of year

AstraZeneca’s new medicines power its growth in first half of year

03 August 2020

The Cambridge-based biopharmaceutical company recorded revenue and profit growth despite the Covid-19 pandemic.


Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

Covid-19 test developed by Avacta and Adeptrix to be evaluated by government’s CONDOR programme

30 July 2020

Move will give the Whittlesford-based company access to patient samples.


Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

Abcam considers NASDAQ listing as it matches previous year’s revenues despite pandemic

29 July 2020

The group expects to report revenues of £260million and is in the midst of a growth strategy.


AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

AstraZeneca agrees potential $6bn oncology collaboration with Daiichi Sankyo

28 July 2020

The deal surrounds antibody drug conjugate DS-1062, which could redefine treatments in lung, breast and multiple other cancers.


Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

Coronavirus vaccine: AstraZeneca and Oxford University encouraged by trial results

20 July 2020

AZD1222 generates both an antibody and T cell response, and appears safe, data shows.


Bit Bio lease means BioMed@Babraham is full after only 12 months

Bit Bio lease means BioMed@Babraham is full after only 12 months

Bit Bio lease means BioMed@Babraham is full after only 12 months

15 July 2020

The human synthetic biology pioneer joins PetMedix, Mission Therapeutics and RxCelerate at the site.


Mission Therapeutics raises £12m and deepens Pfizer relationship

Mission Therapeutics raises £12m and deepens Pfizer relationship

Mission Therapeutics raises £12m and deepens Pfizer relationship

10 July 2020

The new capital will support its world-leading DUB platform.


Gastruloids: Embryo-like model gives researchers a glimpse into black box of early human development

Gastruloids: Embryo-like model gives researchers a glimpse into black box of early human development

Gastruloids: Embryo-like model gives researchers a glimpse into black box of early human development

09 July 2020

University of Cambridge work gives us an insight into the human body plan


Medwise.ai helps clinicians find Covid-19 answers using artificial intelligence

Medwise.ai helps clinicians find Covid-19 answers using artificial intelligence

Medwise.ai helps clinicians find Covid-19 answers using artificial intelligence

09 July 2020

The Cambridge company has won a £40,000 grant from Innovate UK


Cancer Research UK and British Heart Foundation warn Prime Minister they may have to cut £200m from research funding

Cancer Research UK and British Heart Foundation warn Prime Minister they may have to cut £200m from research funding

Cancer Research UK and British Heart Foundation warn Prime Minister they may have to cut £200m from research funding

07 July 2020

An open letter signed by more than 60 scientists - many of them from Cambridge - calls on the Prime Minister to provide urgent financial support.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More